This podcast, hosted by the Comprehensive Opioid, Stimulant, and Substance Use Program (COSSUP), discusses the impact of COVID-19 on Prescription Drug Monitoring Programs (PDMPs).
This podcast will provide the listener with an overview of how the pandemic has affected the operations of a few Prescription Drug Monitoring Programs (PDMPs), and what PDMP administrators are doing to keep this valuable tool operating for healthcare providers and their patients. PDMPs are state government programs that collect information about the prescribing and dispensing of controlled substance medications. Even though controlled substances are effective in the treatment of certain medical conditions, they also have the potential to be misused or abused. PDMPs are tools used by prescribers and dispensers to ensure proper use of these medications and to enhance patient care. There are 54 PDMPs nationally, including programs in the District of Columbia, Puerto Rico, Guam, and the Northern Mariana Islands. This podcast features interviews with four PDMP administrators who discuss the operational adjustments made in response to the pandemic, changes in reporting of prescription information, any indication of any changes in misuse or abuse of prescription medications, review any changes in the prescribing or dispensing patterns resulting from the pandemic, and what the impact the COVID-19 pandemic may have on future budgets and operations of PDMPs.
Similar Publications
- A Care Cascade Analysis of Opioid Use Disorder Services Provided in Jail
- Race and Rationality Revisited: An Empirical Examination of Differential Travel Patterns to Acquire Drugs Across Geographic Contexts
- Implementation of Electronic Health Record Integration and Clinical Decision Support to Improve Emergency Department Prescription Drug Monitoring Program Use